131 related articles for article (PubMed ID: 29765143)
1. Other immunomodulatory agent-related lymphoproliferative diseases: a single-center series of 72 biopsy-confirmed cases.
Marcelis L; Berghen C; De Zutter A; Biesemans P; Vandenberghe P; Verhoef G; Gheysens O; Sagaert X; Dierickx D; Tousseyn T
Mod Pathol; 2018 Sep; 31(9):1457-1469. PubMed ID: 29765143
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases.
Satou A; Tabata T; Miyoshi H; Kohno K; Suzuki Y; Yamashita D; Shimada K; Kawasaki T; Sato Y; Yoshino T; Ohshima K; Takahara T; Tsuzuki T; Nakamura S
Mod Pathol; 2019 Jul; 32(8):1135-1146. PubMed ID: 30952973
[TBL] [Abstract][Full Text] [Related]
3. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders in Cystic Fibrosis Lung Transplant Recipients: A Case Series.
Mendogni P; Henchi S; Morlacchi LC; Tosi D; Nosotti M; Tarsia P; Gregorini AI; Rosso L
Transplant Proc; 2019; 51(1):194-197. PubMed ID: 30655153
[TBL] [Abstract][Full Text] [Related]
6. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.
Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y
Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315
[TBL] [Abstract][Full Text] [Related]
7. Primary Central Nervous System Immunomodulatory Therapy-Induced Lymphoproliferative Disorder in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature.
Alobaid A; Torlakovic E; Kongkham P
World Neurosurg; 2015 Dec; 84(6):2074.e15-9. PubMed ID: 26171889
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
[TBL] [Abstract][Full Text] [Related]
9. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
[TBL] [Abstract][Full Text] [Related]
10. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
[TBL] [Abstract][Full Text] [Related]
11. Post-transplant lymphoproliferative disorders with naso- and oropharyngeal manifestation.
Akbas A; Tiede C; Lemound J; Maecker-Kolhoff B; Kreipe H; Hussein K
Transpl Int; 2015 Nov; 28(11):1299-307. PubMed ID: 26147593
[TBL] [Abstract][Full Text] [Related]
12. Iatrogenic immunodeficiency-associated lymphoproliferative disorders of B-cell type that develop in patients receiving immunosuppressive drugs other than in the post-transplant setting.
Momose S; Tamaru JI
J Clin Exp Hematop; 2019; 59(2):48-55. PubMed ID: 31257345
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulator agent-related lymphoproliferative disorders.
Hasserjian RP; Chen S; Perkins SL; de Leval L; Kinney MC; Barry TS; Said J; Lim MS; Finn WG; Medeiros LJ; Harris NL; O'Malley DP
Mod Pathol; 2009 Dec; 22(12):1532-40. PubMed ID: 19767727
[TBL] [Abstract][Full Text] [Related]
14. In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications.
Gonzalez-Farre B; Rovira J; Martinez D; Valera A; Garcia-Herrera A; Marcos MA; Sole C; Roue G; Colomer D; Gonzalvo E; Ribera-Cortada I; Araya M; Lloreta J; Colomo L; Campo E; Lopez-Guillermo A; Martinez A
Mod Pathol; 2014 Dec; 27(12):1599-611. PubMed ID: 24762547
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death-ligand 1 (PD-L1) axis in post-transplant lymphoproliferative disorders: association with Epstein-Barr virus, PD-L1 copy number alterations, and outcome.
Veloza L; Teixido C; Castrejon N; Climent F; Carrió A; Marginet M; Soldini D; González-Farré B; Ribera-Cortada I; Lopez-Guillermo A; González-Barca E; Sierra A; Herrera M; Gómez C; Garcia A; Balagué O; Campo E; Martinez A
Histopathology; 2019 Dec; 75(6):799-812. PubMed ID: 30861172
[TBL] [Abstract][Full Text] [Related]
16. [Post-transplantation lymphoproliferative disorder in childhood].
Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A
Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879
[TBL] [Abstract][Full Text] [Related]
17. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
[TBL] [Abstract][Full Text] [Related]
18. Induction regimens and post-transplantation lymphoproliferative disorder after pediatric intestinal transplantation: Single-center experience.
Devine K; Ranganathan S; Mazariegos G; Bond G; Soltys K; Ganoza A; Sun Q; Sindhi R
Pediatr Transplant; 2020 Aug; 24(5):e13723. PubMed ID: 32424963
[TBL] [Abstract][Full Text] [Related]
19. EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations.
Courville EL; Yohe S; Chou D; Nardi V; Lazaryan A; Thakral B; Nelson AC; Ferry JA; Sohani AR
Mod Pathol; 2016 Oct; 29(10):1200-11. PubMed ID: 27443517
[TBL] [Abstract][Full Text] [Related]
20. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
Muchtar E; Kramer MR; Vidal L; Ram R; Gurion R; Rosenblat Y; Bakal I; Shpilberg O
Transplantation; 2013 Oct; 96(7):657-63. PubMed ID: 23823652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]